Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
スポンサーリンク
概要
- 論文の詳細を見る
Monitoring minimal residual disease (MRD) in patients with acute lymphoblastic leukemia (ALL) is a useful way for assessing treatment response and relapse. We studied the value of MRD and showed a correlation with relapse for 34 adult patients with ALL. MRD was evaluated by real-time quantitative polymerase chain reaction (RQ-PCR) with probes derived from fusion chimeric genes (BCR/ABL) (n = 12) or PCR-based detection of clonal immunoglobulin and T-cell receptor gene rearrangements (n = 16), or both (n = 6). We analyzed 27 of the 34 patients who could be examined for MRD on day 100 after induction therapy. The overall survival (OS) rate (45.0%) and relapse-free survival (RFS) rate (40.0%) at 2 years in CR patients with MRD level ≥ 10^[-3] (n = 12) were significantly lower than those in CR patients with MRD level < 10^[-3] (n = 15) (OS rate: 79.0%, RFS rate: 79.4%) (log-rank test, P = 0.017 and 0.0007). We also applied multicolor flow cytometry for comparison with MRD results analyzed by PCR methods. The comparison of results obtained in 27 follow-up samples showed consistency in 17 samples (63.0%) (P = 0.057). MRD analysis on day 100 is important for treatment decision in adult ALL.
著者
-
Noto Shun
Stem Cell Transplantation Center Hokkaido University Hospital
-
Tanaka J
Stem Cell Transplantation Center Hokkaido University Hospital
-
Hashino Satoshi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Imamura M
Stem Cell Transplantation Center Hokkaido University Hospital
-
Kawamura Takahito
Department Of Medicine Ii Hokkaido University Graduate School Of Medicine
-
Sato Norihiro
Translational Research And Clinical Trial Center Hokkaido University Hospital
-
Masauzi Nobuo
Department Of Internal Medicine Hakodate Municipal Hospital
関連論文
- DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
- Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation : a case report
- Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier
- TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Incidence and Risk of Postherpetic Neuralgia after Varicella Zoster Virus Infection in Hematopoietic Cell Transplantation Recipients: Hokkaido Hematology Study Group
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological Diagnoses of the Japan Adult Leukemia Study Group Acute Myeloid Leukemia Protocols: Central Review
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer
- Usefulness of magnifying endoscopic evaluation of the terminal ileum for a patient with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
- Proliferation of CD4^+ Lymphocytes in a Patient With Chronic Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation
- Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation
- Cord blood transplantation with a reduced-intensity conditioning regimen for patients with relapsed aggressive multiple myeloma after cytoreduction with bortezomib
- Regimen-Related Mucosal Injury of the Gut Increased the Incidence of CMV Disease after Allogeneic Bone Marrow Transplantation
- Hepatosplenic alpha/beta T cell lymphoma presenting with cold agglutinin disease.
- Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma
- Chronic demyelinating polyneuropathy in graft-versus-host disaese following allogeneic bone marrow transplantation
- Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells
- Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma
- Ciprofloxacin inhibits lipopolysaccharide-induced toll-like receptor-4 and 8 expression on human monocytes derived from adult and cord blood
- Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation
- Acute-Onset Pancytopenia in a Postpartum Lactating Woman
- Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia
- Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia
- Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients
- Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation
- HB Vaccination in the Prevention of Viral Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Previous HBV Infection
- Efficacy and safety of Micafungin in Febrile NeutropenicPatients Treated for Hematological Malignancies
- Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients.
- Aleukemic leukemia cutis in a patient with Philadelphia chromosome-positive biphenotypic leukemia.
- The inhibition of protein C anticoagulant activity by anti-β_2-glycoprotein I (β_2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods
- HCV non-structural protein 3 and HCV RNA genome in non-Hodgkin lymphoma and transition of the serum HCV RNA level : a retrospective analysis in one institution
- A Case of Non-Hodgkin's Lymphoma and Invasive Thymoma Treated with R-CHOP Therapy
- Successful Reduced-intensity Stem Cell Transplantation (RIST) for a Patient with Malignant Lymphoma and an Ileostomy
- Potential Role of Natural Killer Cell Receptor-Expressing Cells in Immunotherapy for Leukemia
- Successful Micafungin (FK463) Treatment of Invasive Pulmonary Aspergillosis in a Patient with Acute Lymphoblastic Leukemia in a Phase II Study
- Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
- Rhabdomyolysis Caused by Distigmine Bromide
- Exfoliative Esophagitis Early After Autologous Peripheral Blood Stem Cell Transplantation
- Allogeneic Bone Marrow Transplantation as a Therapeutic Modality for Hematological Disorders : A Report Based on 39 Cases
- Treatment With Low-Dose Cytosine Arabinoside Followed by Administration of Macrophage Colony-Stimulating Factor Prolongs the Survival of Patients With RAEB, RAEB-T, or Leukemic Phase Myelodysplastic Syndrome: A Pilot Study
- Donor cell leukemia after umbilical cord blood transplantation : recurrent or de novo? The importance of diagnosis for therapeutic decision making
- CARDIOTOXICITY IN HIGH-DOSE CHEMOTHERAPY FOLLOWED BY BONE MARROW TRANSPLANTATION : THE EVALUATION OF LEFT VENTRICULAR FUNCTION
- ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses
- The role of accessory cells in allogeneic peripheral blood stem cell transplantation
- A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells
- Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.
- Synthesis and Pesticidal Activities of Phosphonate Analogs of Amino Acids
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia
- Donor cell leukemia after umbilical cord blood transplantation : recurrent or de novo? The importance of diagnosis for therapeutic decision making
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia
- Expansion of CD4+CD25+ regulatory T cells from cord blood CD4+ cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin
- Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantations
- HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine
- Complete Remission Following Chemotherapy with Low-dose Cytosine Arabinoside and Macrophage Colony-stimulating Factor/Granulocyte Colony-stimulating Factor in a Patient with Relapsed Acute Myeloid Leukemia after Stem Cell Transplantation
- Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies